- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Deep Brain Stimulator.
Displaying page 1 of 1.
EudraCT Number: 2016-002680-34 | Sponsor Protocol Number: DEXPAR | Start Date*: 2016-10-20 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Effects of different concentrations of dexmedetomidine on basal ganglia neuronal activity (local field potentials) in Parkinson's disease. | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000868-17 | Sponsor Protocol Number: DEXPROPAR | Start Date*: 2014-06-26 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Effect of dexmedetomidine vs propofol on basal ganglia activity (local field potentials) recorded through implanted stimulators | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001859-67 | Sponsor Protocol Number: YKP3089C021 | Start Date*: 2015-11-16 |
Sponsor Name:SK Life Science Inc | ||
Full Title: An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures | ||
Medical condition: Partial-onset epilepsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Restarted) BG (Completed) PL (Completed) CZ (Completed) HU (Completed) SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001337-41 | Sponsor Protocol Number: YKP3089C025 | Start Date*: 2018-12-17 | |||||||||||
Sponsor Name:SK Life Science, Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures | |||||||||||||
Medical condition: Primary Generalized Tonic-Clonic Seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) BG (Completed) CZ (Ongoing) SK (Ongoing) PL (Ongoing) DE (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003051-36 | Sponsor Protocol Number: ACP-103-014 | Start Date*: 2008-09-10 | |||||||||||
Sponsor Name:Acadia Pharmaceuticals Inc | |||||||||||||
Full Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) ES (Completed) SE (Prematurely Ended) BE (Completed) PT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003623-37 | Sponsor Protocol Number: CAN-PDP | Start Date*: 2020-02-12 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: CANnabidiol for Parkinson’s Disease Psychosis | |||||||||||||
Medical condition: Parkinson's disease psychosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002906-23 | Sponsor Protocol Number: ACP-103-012 | Start Date*: 2007-11-14 | |||||||||||
Sponsor Name:Acadia Pharmaceuticals Inc | |||||||||||||
Full Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial To Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson's Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003035-22 | Sponsor Protocol Number: ACP-103-015 | Start Date*: 2008-11-05 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) SE (Completed) BE (Completed) AT (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.